Context The rate of tuberculosis (TB) among US homeless persons maybe 20 ti
mes that of the general adult population. Studies suggest that the majority
of urban homeless TB cases are attributable to ongoing transmission of TB.
Optimal TB-control strategies in both chronically and transiently homeless
populations are not known.
Objective To examine the effects of TB-control strategies on projected TB c
ases and deaths in US homeless populations using a computer-based simulatio
n model.
Design, Setting, and Population The US general population and a theoretical
population of 2 million homeless individuals in 1995 were divided into 18
clinical states based on the risk for or presence of TB and human immunodef
iciency virus (HIV) infection in a semi-Markov model.
Main Outcome Measures Prevalence of transiently and chronically homeless in
dividuals with active TB and deaths from TB as a function of public health
measures taken to control and eliminate TB, including improvement of treatm
ent effectiveness, improvement in access to treatment, and vaccination with
BCG.
Results A 10% increase in access to treatment among homeless persons with a
ctive TB produced larger declines in predicted TB cases and deaths after 10
years (cases and deaths among chronically homeless persons decreased 12.5%
and 19.8% and among transiently homeless persons dropped 35.9% and 32.4%,
respectively) than improvements in the effectiveness of treatment programs
(cases and deaths among chronically homeless per-sons declined 7.2% and 3.1
% and among transiently homeless persons dropped 10.9% and 4.1%, respective
ly). A 10% increase in access to treatment among homeless persons with late
nt TB infection led to a 6.7% decline in TB among chronically homeless pers
ons and a 5.7% decline among transiently homeless persons, while a 10% impr
ovement in effectiveness of treatment for latent TB infection was associate
d with declines of 3.0% and 3.3%, respectively. When treatment for latent T
B infection was modeled to be the same in vaccinated and nonvaccinated popu
lations, BCG vaccination led to TB case declines of 15.4% and 21.5% in chro
nically and transiently homeless populations, respectively.
Conclusions Overcoming barriers faced by homeless individuals in accessing
TB treatment programs will be crucial to reducing the burden of TB in this
high-risk group. Increased treatment access, improvement in the effectivene
ss of treatment programs, and BCG vaccination of HIV-negative homeless indi
viduals have the best chance to markedly decrease TB morbidity and mortalit
y.